Do not administer palifermin within 24 hours before, during, or within 24 hours after myelotoxic chemotherapy. Administration within 24 hours resulted in increased severity and duration of oral mucositis.
Source: NLP:palifermin
1 interaction on record
Do not administer palifermin within 24 hours before, during, or within 24 hours after myelotoxic chemotherapy. Administration within 24 hours resulted in increased severity and duration of oral mucositis.
Source: NLP:palifermin